Alejandra Bodelόn

Dr. Alejandra Bodelόn

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
HAHisham I Abu-Tawil
Hisham I Abu-Tawil
LPLucas Wilhelmus Picavet
Lucas Wilhelmus Picavet
EVEllen van Vroonhoven
Ellen van Vroonhoven
ABAlejandra Bodelόn
Alejandra Bodelόn
RSRianne C. Scholman
Rianne C. Scholman
JLJorg van Loosdregt
Jorg van Loosdregt
N6-methyladenosine (m6A) has recently emerged as a post-transcriptional modulator governing cell-specific gene expression in innate immune cells, particularly in monocytes. Disruptions in m6A homeostasis, manifested as the altered expression of m6A-related proteins and m6A levels, have been implicated in autoimmune disorders. Perturbations in m6A dynamics within total Peripheral blood mononuclear cells (PBMCs) have shown strong correlations with disease severity in rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). It remains unclear in which specific cell type(s) m6A homeostasis is disturbed, and also whether other rheumatic diseases such as juvenile idiopathic arthritis (JIA) show similar features. Here, we assess the involvement of m6A and m6A-regulatory proteins in JIA monocytes. Notably, the diminished expression of m6A-eraser proteins FTO and ALKBH5 was observed in JIA monocytes extracted from the inflamed joint. This resulted in increased m6A-methylated transcripts in monocytes from these patients. Correspondingly, we observed that culturing monocytes in the presence of synovial fluid from JIA inflamed joints reduced the expression of both FTO and ALKBH5. The knock-out of FTO in human monocytes of healthy controls increased monocyte activation, indicating the relevance of FTO and m6A in the context of JIA. These findings underscore the potential of ALKBH5 and FTO expression as a biomarker in JIA and identify the m6A machinery as a potential therapeutic target for the treatment of JIA and possibly other autoimmune diseases in the future.

8 April 2025 in Cells
Verified
Journal Article
Open access
PDF file
LNLotte Nijhuis
Lotte Nijhuis
ABAlejandra Bodelόn
Alejandra Bodelόn
RSRianne C. Scholman
Rianne C. Scholman
IHIsabelle Houtzager
Isabelle Houtzager
LSLyanne Sijbers
Lyanne Sijbers
JLJorg van Loosdregt
Jorg van Loosdregt
Chronic inflammation and autoimmune diseases are driven, in part, by the activation of (auto)reactive CD4+ T-cells, highlighting their potential as therapeutic targets for these diseases. Nicotinamide (NAM) has demonstrated anti-inflammatory properties in various disease models and has already demonstrated safety in several large clinical trials in humans. The mechanisms behind these observations, and especially their direct effects on CD4+ T-cells, remain poorly understood. Here, we address this gap by investigating how NAM influences CD4+ T-cell activation and function. We also describe that NAM treatment significantly suppresses CD4+ T-cell activation in vitro, as evidenced by impaired proliferation and reduced expression of surface activation markers. Additionally, NAM treatment resulted in reduced production of pro-inflammatory cytokines, IL-2, IFNy, and IL-17, further highlighting its anti-inflammatory potential. We found that NAM modulates key metabolic processes, including glycolysis and reactive oxygen species (ROS) production—both essential to T-cell activation. Taken together, our findings provide novel mechanistic insight into the regulation of T-cell activation by NAM, suggesting NAM as an attractive candidate for novel therapies targeting immune-related diseases.

30 March 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
DOD. S. Oliveira
D. S. Oliveira
ALAnais Larue
Anais Larue
WNWilliam Vilas Boas Nunes
William Vilas Boas Nunes
FSFrancois Sabot
Francois Sabot
ABAlejandra Bodelόn
Alejandra Bodelόn
CCClaudia Carareto
Claudia Carareto
Host shifts in insects have been considered a key process with the potential to contribute to reproductive isolation and speciation. Both genomics and transcriptomics variation have been attributed to such a process, in which gene families with functions associated with host localization, acceptance, and usage have been proposed to evolve. In this context, cactophilic Drosophila species are an excellent model to study host shift evolution, since they use a wide range of cacti as hosts, and many species have different preferences. Transposable elements are engines of genetic novelty between populations and species, driving rapid adaptive evolution. However, the extent of TEs’ contribution to host shift remains unexplored. We performed genomic and transcriptomic analyses in six genomes of cactophilic species/subspecies to investigate how TEs interact with genes associated with host shift. Our results revealed enrichment of TEs at promoter regions of host shift-related genes, with ∼39% of the odorant receptors containing their transcription factor binding sites within TEs. We observed that ∼50% of these TEs are Helitrons , demonstrating an unprecedented putative cis -regulatory role of Helitrons in Drosophila . Differential expression analysis between species with different preferred hosts revealed divergence in gene expression in head and larval tissues. Although TEs’ presence does not affect overall gene expression, we observed 6.27% of the expressed genes generating gene-TE chimeric transcripts, including those with function affecting host preference. Our combined genomic and transcriptomic approaches provide evidence of TE-driven divergence between species, highlighting the evolutionary role of TEs in the context of host shift, a key adaptive process that can cause reproductive isolation.

3 December 2025 in Cells
Verified
Journal Article
Open access
PDF file
MHMaurice J H van Haaren
Maurice J H van Haaren
ABAlejandra Bodelόn
Alejandra Bodelόn
LSLyanne Sijbers
Lyanne Sijbers
RSRianne Scholman
Rianne Scholman
LPLucas Wilhelmus Picavet
Lucas Wilhelmus Picavet
JLJorg van Loosdregt
Jorg van Loosdregt
Alternative splicing is a key regulator of immune regulation by enabling rapid and context-specific responses. However, the role of splicing regulators such as CDC-like kinase 1 (CLK1) in monocyte biology remains poorly defined. Here, we identify and characterize distinct CLK1-splice isoforms in human CD14+ monocytes using long-read RNA sequencing. In resting monocytes, we observe predominant expression of a truncated isoform lacking exon 4 (CLK1Δ4), which undergoes nonsense-mediated decay resulting in minimal protein output. Lipopolysaccharide (LPS) stimulation induces a shift toward the full-length isoform (CLK1+4), associated with increased transcript stability and protein expression. This splicing switch was confirmed by RT-qPCR, short-read RNA sequencing, and Western blot analysis. Pharmacological inhibition of CLK1 selectively reduced TNFα production without affecting cell viability, implicating that the isoform shift enhances pro-inflammatory signaling. These findings uncover a stimulus-dependent splicing mechanism that modulates monocyte activation through differential CLK1 isoform expression and suggest a potential therapeutic avenue by targeting splicing regulators in immune-related disease with an established role of activated monocytes.

29 May 2026 in Nature Communications
Verified
Journal Article
Open access
ABAlejandra Bodelόn
Alejandra Bodelόn
MHMaurice J H van Haaren
Maurice J H van Haaren
PAPaula Sobrevals Alcaraz
Paula Sobrevals Alcaraz
LSLyanne Sijbers
Lyanne Sijbers
RSRianne C. Scholman
Rianne C. Scholman
JLJorg van Loosdregt
Jorg van Loosdregt
Alternative splicing is a key mechanism for expanding transcriptomic and proteomic complexity, yet its role in innate immune activation remains incompletely understood. Here, we applied Oxford Nanopore native RNA-sequencing to generate an isoform-level transcriptome of primary human monocytes before and after activation with lipopolysaccharide. We identify over 24,000 expressed isoforms, including thousands of previously unannotated variants. Activation induced widespread isoform-specific expression changes, leading to extensive isoform switching events, which were validated using matched short-read RNA-Seq. These activation-induced shifts enhanced transcript immune-regulatory functions: activated monocytes preferentially express longer, coding-competent isoforms with complete open reading frames, fewer retained introns, and increased domain complexity. By integrating matched Ribo-seq and proteomic data, we demonstrate that these isoform modulations are associated with enhanced translation of immune effector proteins. Together, our findings position alternative splicing as a dynamic and functional regulator of monocyte activation, emphasizing the need for isoform-level resolution to fully understand immune cell function.

15 September 2026 in Arthritis & Rheumatology
Verified
Journal Article
Open access
PDF file
GRGreta Rogani
Greta Rogani
RERemco G. A. Erkens
Remco G. A. Erkens
ABAlejandra Bodelόn
Alejandra Bodelόn
TMTim R. Mocking
Tim R. Mocking
MPMarein T. M. Putmans
Marein T. M. Putmans
JLJorg van Loosdregt
Jorg van Loosdregt
Objective: Still disease (SD) is an autoinflammatory disorder characterized by remarkably high interleukin‐18 (IL‐18) levels. Increasing evidence suggests that adaptive immunity also contributes to its pathogenesis, particularly in refractory courses. Macrophage activation syndrome (MAS), one of SD's most severe complications, is associated with further IL‐18 elevation and expansion of CD38 + HLA‐DR + CD8 + T cells. However, whether and when this population emerges during SD remains unknown. We therefore examined CD38 + HLA‐DR + CD8 + T cells across disease stages. Methods: CD38 + HLA‐DR + CD8 + T cells were analyzed longitudinally: at SD onset (therapy‐naive; n = 19), during clinically inactive disease (n = 15), and before or at MAS occurrence (n = 12). Spectral flow cytometry and bulk RNA sequencing were performed. Correlations with clinical and laboratory parameters were assessed. In vitro cytokine stimulations of healthy donor (HD)–derived peripheral blood mononuclear cells and CD8 + lymphocytes were performed to explore mechanisms driving differentiation of these cells. Results: CD38 + HLA‐DR + CD8 + T cells were expanded from SD onset and peaked in MAS (median: 4.61% and 31.7%, respectively, versus 0.87% in HDs). Transcriptomic profiling of these cells revealed enrichment of activation, cytotoxicity, and proliferation programs, which were confirmed at the protein level. Frequencies correlated with markers of systemic inflammation, T cell activation, and serum IL‐18 levels. Sustained IL‐18 stimulation in vitro induced robust and persistent expansion of CD38 + HLA‐DR + CD8 + cells, recapitulating key ex vivo phenotypic features. Conclusion: CD38 + HLA‐DR + CD8 + cells, previously primarily associated with MAS, are detectable early in SD. Persistent IL‐18 exposure promotes their expansion. These findings identify CD38 + HLA‐DR + CD8 + T cells as a potential mechanistic link between SD and MAS and highlight this subset as a candidate therapeutic target. image